← Back to Search

Dietary Supplement

MicAlgae100 for Healthy Subjects (PORPHY-ONE Trial)

N/A
Waitlist Available
Led By David Fukuda, PhD
Research Sponsored by Microphyt
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from 0 to week 4
Awards & highlights

PORPHY-ONE Trial Summary

This trial looks at how a new dietary supplement affects muscle health, energy, pain and inflammation after exercise in young men.

PORPHY-ONE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from 0 to week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and from 0 to week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Neuromuscular function
Secondary outcome measures
C-reactive protein (mg/l)
Creatine kinase (UI/I)
Endurance capacity
+11 more

PORPHY-ONE Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: MicAlgae500Experimental Treatment1 Intervention
2 capsules per day containing 500mg of microalgae based ingredient
Group II: MicAlgae250Experimental Treatment1 Intervention
2 capsules per day containing 250mg of microalgae based ingredient
Group III: MicAlgae100Experimental Treatment1 Intervention
2 capsules per day containing 100mg of microalgae based ingredient
Group IV: Placebo groupPlacebo Group1 Intervention
2 capsules of Maltodextrin per day
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MicAlgae
2023
N/A
~80

Find a Location

Who is running the clinical trial?

MicrophytLead Sponsor
4 Previous Clinical Trials
226 Total Patients Enrolled
University of Central FloridaOTHER
78 Previous Clinical Trials
1,097,396 Total Patients Enrolled
David Fukuda, PhDPrincipal InvestigatorUniversity of Central Florida
1 Previous Clinical Trials
56 Total Patients Enrolled

Media Library

MicAlgae (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05760742 — N/A
Healthy Subjects Research Study Groups: Placebo group, MicAlgae100, MicAlgae250, MicAlgae500
Healthy Subjects Clinical Trial 2023: MicAlgae Highlights & Side Effects. Trial Name: NCT05760742 — N/A
MicAlgae (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05760742 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can elderly individuals aged 35+ participate in this research experiment?

"In order to be eligible for this trial, prospective participants must not exceed 35 years of age and must have reached the legal age of majority."

Answered by AI

What are the eligibility requirements for participating in this clinical trial?

"In order to be eligible for this trial, applicants must possess a clinically sound condition and lie between the ages of 18-35. The researchers are seeking 120 total participants."

Answered by AI

Are new participants being accepted into this clinical trial currently?

"Affirmative. Records hosted on clinicaltrials.gov certify that this scientific experiment, which was first published on 10th January 2023, is actively recruiting volunteers. Around 120 individuals must be enrolled from 1 distinct medical centre."

Answered by AI

How many participants are there in this research initiative?

"Affirmative. According to clinicaltrials.gov, this study initiated acceptance of applicants on January 10th 2023 and was last updated on March 6th 2023. The investigation is seeking 120 individuals from one site for their investigations."

Answered by AI

Who else is applying?

What site did they apply to?
University of Central Florida
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0

Why did patients apply to this trial?

Because i have the time to do it.
PatientReceived 1 prior treatment
~36 spots leftby Apr 2025